Cover Image

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas

Objective: To determine the acceptability and effectiveness of a gonadotropin-releasing hormone (GnRH) agonist for the treatment of perimenopausal women with symptomatic uterine myomas. Materials and Methods: The participants included 43 women with symptomatic myomas who wished to retain their uteri...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peng-Hui Wang (Author), Wen-Ling Lee (Author), Ming-Huei Cheng (Author), Ming-Shyen Yen (Author), Kuan-Chong Chao (Author), Hsiang-Tai Chao (Author)
Format:	Book
Published:	Elsevier, 2009-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unusual Clinical Presentation of Uterine Myomas
by: Ming-Huei Cheng, et al.
Published: (2007)

Medical Treatment for Uterine Myomas
by: Ming-Hui Cheng, et al.
Published: (2008)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014)

Vaginal Expulsion of a Submucosal Myoma During Treatment with Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Lily Wen, et al.
Published: (2006)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
by: Ming-Huei Lin, et al.
Published: (2019)

Fertility outcomes after uterine artery occlusion in the management of women with symptomatic uterine fibroids
by: Hsiang-Tai Chao
Published: (2014)

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
by: Shikha Seth, et al.
Published: (2013)

Short-term advantages of laparoscopic uterine vessel occlusion in the management of women with symptomatic myoma
by: Kuan-Chin Wang, et al.
Published: (2012)

Comparison of gonadotropin releasing hormone agonists (GNRHA) vs aromatase inhibitors on volume of uterine leiomyomas in premenopausal women
by: Uzma Hussain, et al.
Published: (2023)

Does Gonadotropin Releasing Hormone Agonists plus add-back therapy bring an aurora to orthodontic treatment?
by: Jiang Lingyong, et al.
Published: (2012)

Reproductive performance of severely symptomatic women with uterine adenomyoma who wanted preservation of the uterus and underwent combined surgical-medical treatment
by: Wen-Hsun Chang, et al.
Published: (2013)

The impact of gonadotropin-releasing hormone agonist and hormone replacement therapy in placement of hormone replacement therapy on outcomes of IVF after hysteroscopic polypectomy
by: Yiu-Tai Li, et al.
Published: (2024)

Comparing the Use of Uterine Artery Embolization to Gonadotropin-Releasing Hormone Agonists in Shrinking Fibroid Size: A Pilot Study in Kazakhstan
by: Balkenzhe Imankulova, et al.
Published: (2015)

Standard and Low-dose Hormone Therapy for Postmenopausal Women-Focus on the Breast
by: Peng-Hui Wang, et al.
Published: (2007)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
by: Binarwan Halim, et al.
Published: (2022)

Commentary on "Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty"
by: Chong Kun Cheon
Published: (2021)

The changes of surgical treatment for symptomatic uterine myomas in the past 15 Years
by: Weihong Yang, et al.
Published: (2018)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016)

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty
by: Shinyoung Jang, et al.
Published: (2023)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
by: Jong Wan Yoon, et al.
Published: (2017)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
by: Hye Ryun Kim, et al.
Published: (2017)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
by: Mo Kyung Jung, et al.
Published: (2014)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
by: Dattaprasad B Inamdar, et al.
Published: (2012)

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
by: Chen Q, et al.
Published: (2019)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
by: Loukia Sifaki, et al.
Published: (2019)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
by: Neena Malhotra, et al.
Published: (2013)

Delayed postpartum hemorrhage secondary to idiopathic rupture of right uterine artery: A case report and literature review
by: Fan-Hlan Koo, et al.
Published: (2014)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
by: Francesca Poggio, et al.
Published: (2019)

Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
by: Kuo Yong-fang, et al.
Published: (2008)

Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
by: Lindsey Yoojin Chung, et al.
Published: (2020)

Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study
by: Abbas Aflatoonian, et al.
Published: (2018)

Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study
by: Nalini Mahajan, et al.
Published: (2016)

An adenomyomatous polyp presenting as a large hypervascular tumor and its response to a gonadotropin-releasing hormone agonist
by: Yu-Hung Lin, et al.
Published: (2013)

Comparison of letrozole with gonadotropin-releasing hormone agonist in frozen embryo transfer after recurrent implantation failure: An RCT
by: Nayere Khadem Ghaebi, et al.
Published: (2020)

Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection
by: Dehghani Firouzabadi Razieh, et al.
Published: (2009)

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs
by: E M Savelyeva, et al.
Published: (2016)

Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases
by: Zhenhong Wang, et al.
Published: (2022)

Unexpected poor oocyte retrieval: the phenomenon of the borderline response to the gonadotropin-releasing hormone (GnRH) agonist trigger
by: Richard J. Paulson, M.D., M.S
Published: (2024)